Pfizer’s COVID Vax Not Effective for Younger Children Six Weeks Post-Injection: Government Study

A recent study of more than a million children shows that Pfizer’s mRNA COVID-19 vaccine has negative efficacy for the youngest children it’s recommended for.

QUICK FACTS:
  • The efficacy of Pfizer’s mRNA COVID-19 vaccine for the youngest portions of the population authorized to receive it have been discovered to be negative, by the sixth week after full vaccination, according to Just The News.
  • These results were buried in the findings of a study of more than 1.2 million New York children across the duration of Omicron variant’s emergence.
  • The study showed that beginning at day 35 post-injection, the vaccine efficacy (VE) goes negative for 5-11 year-olds and continues to get worse over time.
  • California Gov. Gavin Newsom’s office commented on the findings telling Just the News that the study won’t change his vaccine mandate plan for schools.
OTHER DETAILS FROM THE STUDY:
  • “Negative VE values observed in later timepoints likely reflect estimator instability and/or residual confounding, as opposed to true relatively-increased risk for those vaccinated,” a footnote reads.
  • “These results highlight the potential need to study alternative vaccine dosing for children and the continued importance [of] layered protections, including mask-wearing, to prevent infection and transmission,” the study concluded.
BACKGROUND:
  • Currently, the COVID-19 vaccines are recommended for children aged 5-11, possibly up to two doses, according to People.
  • Pfizer recently postponed its Food and Drug Administration application as the company seeks more data for children under 5 who are not considered eligible at this time.